Harbin Gloria Pharmaceuticals Co Ltd (Harbin Gloria) is a pharmaceutical company that produces and markets nutritional drugs. The company’s products include pharmaceutical drugs for treating nutrition disorders, cancer, cardiovascular diseases, anti-tumor medication, respiratory medication, and musculoskeletal disorders. Its pipeline products include anti-infectives; and irritable bowel syndrome with constipation in women, lubiprostone, ropivacaine mesylate for injection, antihistamine, vitamins and minerals, sodium creatine phosphate for injection, bupixiaoji oral solution, annao and olmesartan medoxomil tablets. The company also collaborates with hospitals and institutions to carry out its research activities. Harbin Gloria is headquartered in Beijing, China.
Headquarters
China
Address
Building 28, Ronghuiyuan, Yuhua Road, Area B, Airport Dev Zn,Shunyi Dist, Beijing, 101318
Website
www.gloria.cc
Telephone
86 10 80479607
No of Employees
4,769
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
002437 (SHE)
Revenue (2021)
$487.7M
-39.6%
(2021 vs 2020)
EPS
XXX
Net Income (2021)
XXX
115%
(2021 vs 2020)
Market Cap*
$818.4M
Net Profit Margin (2020)
XXX
124.9%
(2021 vs 2020)
* As of and is in US$
Explore premium data & analytics
Products and Services
| Products | Brands |
|---|---|
| Sodium Creatine Phosphate for Injection | Xinmeijia |
| Annao Pills | Weimeijia |
| Annao Tablets | Budaxiu |
| XXX | XXX |
| XXX | XXX |
| XXX | XXX |
Competitor Comparison
| Key Parameters | Harbin Gloria Pharmaceuticals Co Ltd | Zhejiang Huahai Pharmaceutical Co Ltd | Tianjin Tianyao Pharmaceuticals Co Ltd | Sihuan Pharmaceutical Holdings Group Ltd | CSPC Innovation Pharmaceutical Co Ltd |
|---|---|---|---|---|---|
| Headquarters | China | China | China | China | China |
| City | Beijing | Taizhou | Tianjin | Beijing | Shijiazhuang |
| State/Province | Beijing | Zhejiang | Tianjin | Beijing | Hebei |
| No. of Employees | 4,769 | 7,019 | 2,635 | 4,282 | 1,524 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Operating Margin
EPS (Earnings per Share)
Debt to Equity Ratio
Return on Assets
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Jiman Zhu | Chairman | Executive Board | - | - |
| Dongxu Wang | Vice Chairman | Executive Board | - | - |
| Xiuqiang Diao | Director; Deputy General Manager; Chief Financial Officer | Executive Board | - | - |
| Liu Yueyin | Deputy General Manager | Senior Management | - | - |
| Zhou Kang | Deputy General Manager | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2022 | XX |
| Non Dignissim Eros | Proin vel | Convallis | 2022 | XX |
| Non Dignissim Eros | Proin vel | Convallis | 2022 | XX |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer